Tigermed (03347) has issued an announcement regarding the matter of its Director and Controlling Shareholders, Mr. Ye Xiaoping and Ms. Cao Xiaochun, receiving a case filing notice from the China Securities Regulatory Commission (CSRC). The company has noted market speculation on whether Mr. Ye and Ms. Cao have conducted public announcements and disclosures in accordance with regulations. After making reasonable inquiries relevant to the company under the circumstances, Tigermed hereby clarifies and emphasizes that the content of the case filing investigation pertains to matters related to information disclosure during the historical changes in shareholdings of Mr. Ye and Ms. Cao. All historical share reductions by the two actual controllers have been duly announced, and their shareholding status has also been disclosed in the company's periodic reports. The parties responsible for information disclosure have additionally disclosed the "Simplified Change in Equity Interests Report." The aforementioned matter is unrelated to the company's business operations and will not affect the normal business operations of the company.